Most people have never heard of causal learning, but the concept is an important one for the future of healthcare because it holds the key to understanding and fighting disease and improving outcomes. However, to understand how and why causality is so important in the fight for better healthcare, we have to first understand machine learning.
You may be familiar with the term “artificial intelligence”, which is a broader umbrella term that machine learning falls within. Anarticle in Xconomypublished earlier this year goes into detail on artificial intelligence (AI) and starts by talking...
Now it’s time to introduce you to Iya Khalil, who co-founded GNS Healthcare with Colin Hill and serves as the company’s Chief Commercial Officer. When I sat down to talk with Iya, I wanted to get her insights into the company’s work and how it was going to bring its’ industry leading capabilities to more businesses and situations. I also wanted to know more about what the company is doing to identify and fight disease. She was able to help me understand how GNS is working with partners to improve the application of GNS’ solutions and the important work that remains to be accomplished. Now the...
As we’re getting the ball rolling with our new blog, we agreed that there couldn’t be a better way to kick things off than with an interview with GNS Healthcare CEO, Chairman, and co-founder Colin Hill. So when I had the chance to sit down for a discussion with Colin, what I wanted to know was what was the vision that convinced him to found GNS seventeen years ago and does that mission still hold true today. What I found is that he has been driven by one seemingly simple question: What needs to be discovered and uncovered to stop disease and its progression? He’s had a clear vision since 2000...
Our blog will be a forum for discussion – to tackle important issues in precision medicine and focus on how machine learning and artificial intelligence are being applied to improve health outcomes and lower the total cost of care. We’ll discuss topics like healthcare’s matching problem and how big ‘patient’ data can be used to discover which health interventions work for which patients. We’re excited to host this conversation.
While we don’t develop the drugs, or sell the health insurance plans, or treat patients, we work closely with health plans, biopharmaceutical companies, health...
